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ABSTRACT
Objective The gynaecological environment can become
contaminated by human papillomavirus (HPV) from
healthcare workers’ hands and gloves. This study aimed
to assess the presence of HPV on frequently used
equipment in gynaecological practice.
Methods In this cross-sectional study, 179 samples
were taken from fomites (glove box, lamp of a
gynaecological chair, gel tubes for ultrasound,
colposcope and speculum) in two university hospitals
and in four gynaecological private practices. Samples
were collected with phosphate-buffered saline-humidiﬁed
polyester swabs according to a standardised pattern, and
conducted twice per day for 2 days. The samples were
analysed by a semiquantitative real-time PCR. Statistical
analysis was performed using Pearson’s χ2 test and
multivariate regression analysis.
Results Thirty-two (18%) HPV-positive samples were
found. When centres were compared, there was a higher
risk of HPV contamination in gynaecological private
practices compared with hospitals (OR 2.69, 95% CI
1.06 to 6.86). Overall, there was no difference in the
risk of contamination with respect to the time of day
(OR 1.79, 95% CI 0.68 to 4.69). When objects were
compared, the colposcope had the highest risk of
contamination (OR 3.02, 95% CI 0.86 to 10.57).
Conclusions Gynaecological equipment and surfaces
are contaminated by HPV despite routine cleaning. While
there is no evidence that contaminated surfaces carry
infectious viruses, our results demonstrate the need for
strategies to prevent HPV contamination. These
strategies, based on health providers’ education, should
lead to well-established cleaning protocols, adapted to
gynaecological rooms, aimed at eliminating HPV
material.
INTRODUCTION
Human papillomaviruses (HPVs) are small double-
stranded DNA viruses with a circular genome,
which is enclosed in a naked capsid. HPVs infect
the stratiﬁed epithelium of the skin, of the oral
cavity and of the anogenital tract by accessing kera-
tinocytes through micro-wounds and lesions.1 The
majority of infections are cleared within 2 years.
However, persistence of HPV and the associated
chronic infection play a major role in the develop-
ment of cervical cancer.2 Therefore, HPV is esti-
mated to be responsible for up to 99% of cervical
cancers,3 90% of anal cancers,4 65% of vaginal
cancers,4 50% of vulvar cancers4 and 45%–90% of
oropharyngeal cancers.5 HPVs are classiﬁed into
high-risk HPV (HR-HPV) with malignant potential
and low-risk HPV (LR-HPV) causing benign
lesions.1
There is conﬂicting evidence for HPV transmis-
sion. While skin-to-skin and mucosa-to-mucosa
contact, which is predominantly by sexual inter-
course, is the most frequent route of transmission,
other routes might be involved. Several studies
have highlighted non-sexual HPV transmission
such as vertical transmission from mother to
infant,6 possibly through the amniotic ﬂuid or the
placenta or via contact with the maternal genital
mucosa during delivery.7
Besides direct human transmission of HPV by
sexual intercourse, infection may also result from
contact with contaminated equipment at gynaeco-
logical examination rooms. HPV can persist in
various environmental conditions and resist disin-
fection by desiccation and ethanol because of its
capsid properties.8 Therefore, the possibility of
horizontal transfer of HPV cannot be excluded.9–11
HPV has been detected under ﬁngernails of patients
affected with genital warts and in their underwear.12
Furthermore, HPV is also detected on several
medical instruments, such as vaginal ultrasound
probes and cryoguns.13 14 These data support the
notion that gynaecological facilities might confer a
risk of horizontal transfer, being frequently visited
by infected patients. In addition, gynaecological
examinations may cause micro-trauma of the genital
mucosa favouring HPV infection.
This study aimed to assess whether HPV can be
identiﬁed on certain types of inanimate surfaces
and objects that are commonly used in gynaeco-
logical care. The panel of fomites that we selected
has not been previously studied, and these are used
in an everyday gynaecological practice.
METHODS
Study setting
In this cross-sectional study, samples were collected
from fomites twice a day during 2 days at all study
locations in October 2013. The study took place in
four consulting rooms of the Gynaecology
Department of the University Hospitals of Geneva,
four consulting rooms of the Gynaecology
Department of the University Hospital of Lausanne
and four gynaecological private practices located in
Geneva. Among the four consulting rooms in hos-
pitals, there were two outpatient consultation
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rooms, one colposcopy room and one gynaecological emer-
gency room. Besides the colposcopy room, where patients
usually have Pap smear abnormalities, the other consulting
rooms were used for a wide variety of patients with different
complaints. Permission to visit the gynaecological care room to
collect the samples was obtained by the head chief of the obste-
trics and gynaecology department. All fomites were sampled in
the morning before the ﬁrst consultation and in the evening
after all consultations, but before ﬁnal cleaning (tables 1 and 2).
This study did not include any information on patients, and did
not test human samples. Therefore, the local ethics committee
considered that patient consent was not required.
Sampling
A total of 179 samples were taken from glove boxes (N=48),
lamps (N=48), gel tubes for ultrasound (N=39), colposcope
handles (N=20) and from specula (N=24) (ﬁgure 1). Flocked
swabs (FLOQSwabs 552C; Copan, Brescia, Italy) were used.
These swabs contain a plastic applicator in a sterile dry tube
ﬁlled with 1 ml of sterilised RNA-free and DNA-free phosphate-
buffered saline (PBS) (Sigma, Saint-Louis, Missouri, USA).
Manipulation of the samples was performed under a laminar
ﬂow hood. Quality control was performed for every manipula-
tion using negative control samples containing PBS only. Each
surface was sampled according to a standardised pattern with
PBS-humidiﬁed ﬂocked swabs. After sampling, the swabs were
immediately suspended in 1 ml of PBS and stored at 4°C. Delay
between sampling and laboratory processing was not more than
a maximum of 14 days.
DNA extraction
Tubes containing swabs were vortexed for 3×15 s. A volume of
400 ml of each sample was used for DNA extraction, and the
rest of the sample was frozen and stored. DNA extraction was
performed using the m2000sp with the sample preparation
system kit DNA (Abbott Molecular, Illinois, USA) according to
the manufacturer’s recommendations. All nucleic extracts were
then stored at −20°C pending real-time PCR.
DNA ampliﬁcation and genotyping: detection and genotyping
were performed with the Anyplex II HPV28 test (HPV28;
Seegene, Seoul, South Korea), according to the manufacturer’s
recommendations. HPV28 uses proprietary HPV-speciﬁc DPO
and TOCE technologies15 to achieve HPV genotyping with high
sensitivity and speciﬁcity. A total of 28 HPV genotypes (19
HR-HPVs (16,18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58,
59, 66, 68, 69, 73 and 82) and 9 LR-HPVs (6, 11, 40, 42, 43,
44, 54, 61 and 70)) can be distinguished by the Seegene guide-
book in only two reactions using the CFX96 real-time PCR
instrument (Bio-Rad), provided together with the HPV28 kits
(Seegene) by BÜHLMANN Laboratories AG, Schönenbuch,
Switzerland. This assay has been shown to be sensitive and spe-
ciﬁc, with a detection limit of at least ﬁve genome equivalents
per PCR for the main HR genotypes of 16 or 18.16 A test
sample quality control based on the beta-globin gene was per-
formed to detect the presence of human DNA in the samples.
Statistical analysis
Data are expressed as percentages. The Pearson χ2 test was used
to assess the relationship between each independent variable
and the risk of HPV contamination (table 1). Multivariate logis-
tic regression analysis included all variables with p<0.10 in the
bivariate analysis to identify the predictors of HPV contamin-
ation. The variables included material, location, room and time
of day (table 2). Statistical signiﬁcance was accepted for p values
≤0.05, and 95% CIs were calculated for results. ORs were
adjusted for different potential confounders, such as the mater-
ial, location and time of day. Data were analysed with the statis-
tical analysis software package Stata 2009 (Stata Statistical
Software: Release 11) (Stata, College Station, Texas, USA).
RESULTS
HPV DNA was detected in 32 out of the 179 (17.9%) fomite
samples. The prevalence of HPV varied according to the loca-
tion, room, material and time of day. The distribution of HPV
contamination of the fomites is shown in table 1. Bivariate
Table 1 Distribution of HPV contamination of 179 fomites according to location, material and time of day
Variable
High-risk HPV
contamination
p Value
Low-risk HPV
contamination
p Value
Contamination*
p ValueNo (n=159) Yes (n=20) No (n=155) Yes (n=24) No (n=147) Yes (n=32)
Location 0.264 0.091 0.008
Hospital (n=110) 100 (62.9) 10 (50.0) 99 (63.9) 11 (45.8) 97 (66.0) 13 (40.6)
Private practice (n=69) 59 (37.1) 10 (50.0) 56 (36.1) 13 (54.2) 50 (34.0) 19 (59.4)
Room <0.001 <0.001 <0.001
Ambulatory room (n=50) 49 (30.8) 1 (5.0) 49 (31.6) 1 (4.2) 48 (32.6) 2 (6.2)
Colposcopy room (n=28) 19 (12.0) 9 (45.0) 18 (11.6) 10 (41.6) 17 (11.6) 11 (34.4)
Emergency room (n=32) 32 (20.1) 0 32 (20.7) 0 32 (21.8) 0
Private practice room (n=69) 59 (37.1) 10 (50.0) 56 (36.1) 13 (54.2) 50 (34.0) 19 (59.4)
Material <0.001 <0.001 <0.001
Lamp (n=48) 41 (25.8) 7 (35.0) 38 (24.5) 10 (41.7) 36 (24.5) 12 (37.5)
Glove box (n=48) 47 (29.5) 1 (5.0) 46 (29.7) 2 (8.3) 45 (30.6) 3 (9.4)
Colposcope (n=20) 9 (5.7) 11 (55.0) 10 (6.4) 10 (41.7) 6 (4.1) 14 (43.8)
Specula (n=24) 23 (14.5) 1 (5.0) 24 (15.5) 0 23 (15.6) 1 (3.1)
Gel tubes (n=39) 39 (24.5) 0 37 (23.9) 2 (8.3) 37 (25.2) 2 (6.2)
Time of day 0.539 0.045 0.111
Morning (n=101) 91 (57.2) 10 (50.0) 92 (59.4) 9 (37.5) 87 (59.2) 14 (43.8)
Evening (n=78) 68 (42.8) 10 (50.0) 63 (40.6) 15 (62.5) 60 (40.8) 18 (56.2)
*Independent of HPV risk category.
HPV, human papillomavirus.
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analysis (table 1) allowed the selection of the variables for the
multivariate model (table 2).
Location and room
A total of 110 samples were collected in the hospitals; out of
which, 13 (11.8%) were found to be positive for HPV
compared with 19 (27.5%) positive samples collected in private
practices. HPV contamination was 2.7 times more frequent in
gynaecological private practices than in hospitals (95% CI 1.06
to 6.86, p=0.038). There was a higher risk to detect HPV in a
colposcopy room than in an outpatient room (OR 8.9, 95% CI
1.52 to 51.81, p=0.015).
Table 2 Multivariate logistic regression of factors associated with HPV contamination (high-risk HPV, low-risk HPV and in general)
Variable High-risk HPV contamination Low-risk HPV contamination Contamination*
OR† (95% CI) p Value OR† (95% CI) p Value OR† (95% CI) p Value
Location
Hospital (n=110) 1 (reference) 1 (reference)
Private practice (n=69) 9.82 (1.14 to 84.82) 0.038 2.70 (1.06 to 6.86) 0.038
Room
Ambulatory room (n=50) 1 (reference) 1 (reference) 1 (reference)
Colposcopy room (n=28) 9.65 (1.00 to 93.5) 0.050 22.31 (2.29 to 217.46) 0.008 8.87 (1.52 to 51.81) 0.015
Emergency room (n=32) 0 0 0
Private practice room n=69) 4.62 (0.50 to 42.69) 0.176 9.82 (1.13 to 84.82) 0.038 7.12 (1.41 to 35.88) 0.017
Material
Lamp (n=48) 1 (reference) 1 (reference) 1 (reference)
Glove box (n=48) 0.11 (0.01 to 0.97) 0.047 0.12 (0.02 to 0.67) 0.015 0.16 (0.04 to 0.66) 0.011
Colposcope (n=20) 3.48 (0.97 to 12.5) 0.056 1.56 (0.45 to 5.39) 0.482 3.02 (0.86 to 10.57) 0.085
Specula (n=24) 0.25 (0.03 to 2.51) 0.240 0 0.14 (0.015 to 1.36) 0.091
Gel tubes (n=39) 0 0.24 (0.04 to 1.34) 0.105 0.15 (0.03 to 0.82) 0.029
Time of day
Morning (n=101) 1 (reference)
Evening (n=78) 2.27 (0.78 to 6.57) 0.132
*Independent of HPV risk category.
†Adjusted for time of day, material and location.
HPV, human papillomavirus.
Figure 1 Samples were taken from the (A) black lamp, (B) glove box, (C) white lamp (D) colposcope handle and (E) lubricant’s tube. Arrows point
the exact location where samples were taken from the object.
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Material
Of the 32 positive samples, the majority was found to be asso-
ciated with colposcopes (43.8%) and lamps (37.5%).
Colposcope had a higher probability of being contaminated
with HR-HPV compared with lamps (OR 3.48, 95% CI 0.97 to
12.5, p=0.056).
Time of day
No difference was found in HPV contamination between
morning and evening (OR 2.27, 95% CI 0.78 to 6.57,
p=0.132).
HPV genotype: a panel of 20 genotypes of HPV was detected
in this study, consisting of 13 different HR-HPV genotypes (31,
35, 39, 51, 52, 53, 56, 58, 59, 66, 68, 73 and 82). The most
frequent types among HR-HPV genotypes were HPV 53 and
HPV 58 (14.3% each) followed by HPV 56, 59 and 66 (11.9%
each); HPV 31, 35 and 73 (7.1% each); HPV 68 (4.8%) and
HPV 39, 51, 52 and 82 (2.4% each).
For LR-HPV, seven different genotypes were found (6, 11,
42, 43, 44, 54 and 61). HPV 42 was the most frequent
LR-HPV (38.2%), followed by HPV 6 (17.6%). HPV 11 repre-
sented 2.9% of LR-HPV detected.
Test sample quality control
A test sample quality control based on the beta-globin gene was
performed to detect the presence of human DNA in the
samples, indicating that human cells can be present on surfaces.
Overall, 95 of 179 (53.1%) samples were positive for the ampli-
ﬁcation of beta-globin. Of the 32 samples containing HPV
DNA, 29 (90.6%) were also positive for beta-globin DNA.
DISCUSSION
In this study, 18% of 179 objects, which are part of gynaeco-
logical care, were contaminated by HPV (table 1). Our study
shows that HPV contamination of fomites is a reality, despite
careful cleaning. These ﬁndings are in accordance with previous
studies.9 13 14
Contrary to our initial expectations, we found more contami-
nated fomites in gynaecological private practices than in hospi-
tals (59.4% vs 40.6%). The opposite result was expected
because there is a higher inﬂux of patients consulting at hospi-
tals than at private practices. These patients are more likely to
be infected with HPV, especially in the colposcopy rooms,
because they are probably referred by their gynaecologist. In
addition, hospital personnel were not informed of the exact
date of the sampling for the study. However, for organisational
reasons, the private practices were aware of the exact date of
sampling. This inequality could have created a bias favouring
cleaning in private practices because they could have thoroughly
cleaned the environment, being aware of the exact day of the
sampling. However, the difference in contamination between
hospitals and private practices may be explained by the fact that
hospitals might use stronger cleaning agents. Moreover, hospi-
tals might have a stricter cleaning policy for the cleaning staff
and nurses and more frequent cleaning.
The highest prevalence of HPV was found in colposcopy
rooms (34.4%), whereas the HPV prevalence found in the
ambulatory rooms was of 6.2%. Patients who are referred for
colposcopy are more likely to be HPV carriers than patients
consulting in other care rooms. Surprisingly, no HPV was
detected in emergency rooms, but these rooms receive the
highest number of patients. A stricter behaviour in relation to
disinfection was observed in the emergency rooms. Nurses are
in charge of cleaning in the rooms in between patients, which is
not always the case in regular consulting rooms or gynaeco-
logical private practices.
Our ﬁnding that the colposcope handle was the most con-
taminated object (43.8% of the cases) can be explained by its
structure with several grooves, which are difﬁcult to thoroughly
clean. Moreover, patients who need a colposcope examination
are more likely to be HPV carriers, thus increasing the probabil-
ity of contamination from colposcopes. The lamp also had a
high prevalence of HPV (37.5%). During a gynaecological
examination, the lamp often needs to be repositioned, especially
the black lamps, which have a smaller beam than the white
lamps (ﬁgure 1A,C). In addition to more frequent repositioning
of black lamps, which may lead to an increased risk of contam-
ination, black lamps have a grainy surface, which leads to clean-
ing obstacles, consistent with a higher probability of detection
of HPVat their surface.
A few glove boxes were HPV positive during this study
(9.4%). These boxes were manipulated by many different
people without any precautions.
The presence of HPV on ultrasound gel tubes (6.2% of the
cases) could have resulted from doctors touching the probe with
the gel tube while performing an ultrasound examination.
Surprisingly, one speculum was found to be positive for HPV
DNA. Contamination during sampling cannot be excluded,
despite all of the precautions that are taken. These precautions
include disinfection of hands, wearing gloves and sampling con-
ducted with two people of whom one ensures that the swab
does not touch anything, but the fomite. Another possibility is
that the detected HPV DNA originates from the sterilisation
procedure of the speculum (a reusable speculum) or from its
packing.17 A further possible explanation might be an error
during the laboratory positive analysis, leading to a false-result.
In the current study, we did not ﬁnd differences between
detection of HPV in the morning or evening (43.8% vs 56.2%,
p=0.111), but this was expected from the cumulative examin-
ation of possibly infected patients throughout the day.
HPV 53 was considered a high-risk genotype in this study
according to the Seegene guidebook. HPV 53 was classiﬁed by
the International Agency for Research on Cancer as a probable
high-risk type, but this agency has not recommended its inclu-
sion into HR-HPV diagnostics.2 18 19
We found that 53.1% of the samples were positive for beta-
globin and the human DNA that was found in these samples
probably came from the genital tract or other mucosa.
Our study has some limitations that need to be addressed.
First, our study did not assess the presence of infectious virus
on surfaces because it is only based on nucleic acid detection.
Evaluation of infectious HPV is extremely difﬁcult. The produc-
tion of the virus depends on terminal differentiation of infected
keratinocytes.20 Several studies have attempted to evaluate
infectivity using the organotypic (raft) culture system.21 22
Second, the exact quantity of virus that was present on objects
was not assessed because the Anyplex II HPV28 is a semiquanti-
tative assay.
Our results suggest that the following procedures could be
performed. Because contaminated fomites are usually due to
errors of manipulations, one way of avoiding this would be to
make a protocol for healthcare workers. From the moment that
the gynaecologist starts the physical examination, he/she should
not further touch the environment. An example of this situation
is that a nurse could be present to adjust the light during the
examination or to provide a new set of gloves if needed.
Another suggestion is to replace the black lamps (ﬁgure 1A) by
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other lamps that are easier to clean. Furthermore, disposable
speculums could be preferred over reusable speculums to
prevent contamination. Replacement of the big bottles of gel
tubes with single-dose bottles could also be a solution to avoid
HPV DNA on ultrasound probes.
Finally, our study highlights the issue concerning the efﬁciency
of disinfection agents. A recent study showed that HPV 16 is
resistant to several disinfectant agents that are sometimes used as
sterilising agents (eg, glutaraldehyde and ortho-phthalaldehyde)
in medical facilities.8 Nevertheless, hypochlorite and high con-
centrations of peracetic acid-silver-based disinfectant were found
to be efﬁcient against HPV 16.8 This previous study suggests that
genotypes other than HPV 16 could be resistant to several disin-
fectants that are used in healthcare facilities and that a better dis-
infectant needs to be identiﬁed.
Key messages
▸ There is a signiﬁcant presence of HPV DNA on
gynaecological fomites (mostly on lamps and colposcopes).
▸ There is no evidence that the HPV DNA that is found on
fomites is infectious because the virus cannot be cultivated.
▸ Prevention of contamination is essential because of the
potential carcinogenic impact of the virus, and improvement
in gynaecologists’ habits and efﬁcient cleaning substances
are required.
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